ResourcesVendorsLeica Biosystems1700 Leider Ln Lincolnshire, IL, USA 60069Latest from Leica BiosystemsFDA ClearanceLeica Biosystems, Sectra receive FDA 510(k) clearance for digital pathology systemBy LabPulse.com staff writersLeica Biosystems has received 510(k) clearance from the U.S Food and Drug Administration (FDA) for its Aperio GT 450 DX digital pathology system, in conjunction with Sectra's digital pathology software.May 2, 2024Pathology, histologyLeica Biosystems granted FDA clearance for Class II mismatch repair panelBy LabPulse.com staff writersThe Bond MMR Antibody Panel is available for clinical use on its automated Bond-III and Bond-Max immunohistochemistry instruments.April 3, 2023Pathology and AIPaige, Leica Biosystems expand partnership to enhance digital pathology workflowsBy LabPulse.com staff writersUnder the partnership, a co-branded version of Paige’s pathology platform will be introduced as the core interface between pathologists and Leica Biosystems hardware.March 13, 2023Business InsightsWeek in Review: Roche, Abbott, Quest, Danaher report financial results, provide perspectives on COVID-19 testing salesBy Leo O'ConnorOctober 21, 2022Financial ResultsDanaher Q3 diagnostics revenues rise 9%By LabPulse.com staff writersThird-quarter year-over-year core revenue growth within diagnostics was 14%, with Cepheid growing about 30%.October 20, 2022HPVBio-Techne launches HPV assay in EuropeBy LabPulse.com staff writersRNAscope in situ hybridization (ISH) is a highly sensitive and specific spatial biology technology, Bio-Techne said.July 5, 2022Pathology, histologyLeica introduces Bond-Prime staining systemBy LabPulse.com staff writersThe company said the system's automation works in tandem with Novocastra premium reagents to produce staining in an average of 90 minutes.May 19, 2022Clinical TrialLeica and Leap to partner on new DKK1 cancer assayBy LabPulse.com staff writersThe test will support clinical development of Leap's anti-DKK1 cancer therapy, DKN-01, which is currently in clinical trials. DKK1 is a protein often found in cancer that enables tumor cells to suppress the immune system; overexpression of it has been linked to poor survival in cancer patients, according to the two firms.January 30, 2022Pathology, histologyLeica adds DICOM support to pathology slide scannerBy LabPulse.com staff writersThe DICOM imaging module is now available for customers in selected countries, according to Leica.June 17, 2021Artificial IntelligencePaige and Leica form partnershipBy LabPulse.com staff writersThe partnership brings together Paige's artificial intelligence research software for tumor detection, grading, and quantification and Leica Biosystems' digital pathology platform in select countries throughout North America and Europe.April 21, 2021WebinarsThe H&E stain: A lesson on consistency and reproducibilityOn-Demand Webinar -- Producing a hematoxylin and eosin (H&E) stained slide is a process that starts before the slide is loaded on a stainer or moved down through containers by hand.December 21, 2020WebinarsDealing with fixation of fatty tissue in histologyThis webinar will review fatty specimens and why they are so difficult to process and then provide an overview of the different technologies for processing and solutions used. Finally, it will cover the best techniques for processing fatty specimens.November 1, 2020ConsumerTop companies earn 80% of revenue in IVD marketBy Bruce CarlsonIn recent years, this group of top-tier companies has increased its ownership position of the market. At the same time, Kalorama found that there are still opportunities for new companies. Roche and Abbott are world market leaders, according to the firm's report titled "Worldwide Market for In Vitro Diagnostic Tests," published in August.September 10, 2020WebinarsGetting your lab ready for digital pathologyAugust 13, 2020HomeGetting your lab ready for digital pathologyAugust 12, 2020